Is there any prognostic importance of pretreatment serum M30 and serum M65 levels on progression-free survival of patients with metastatic renal cell carcinoma treated with first-line sunitinib?

BAŞARAN M., Yildiz İ., Sen F., Kilic L., Keskin S., Darendeliler E., ...More

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31, (Summary Text) identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 31
  • City: Illinois
  • Country: United States Of America
  • Acibadem Mehmet Ali Aydinlar University Affiliated: No